Founded 1992


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Average round size
The average size of a deal this fund participated in
Portfolio companies 1
Lead investments 0
Key employees 1
Stages of investment
Private Equity

Areas of investment

  • Health Care
  • Medical Device
  • Therapeutics

Cogepa appeared to be the VC, which was created in 1992. The leading representative office of defined VC is situated in the Paris. The company was established in Europe in France.

The fund is generally included in less than 2 deals every year. The important activity for fund was in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars.

For fund there is no match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Medical Device, Therapeutics. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Allurion Technologies.

The typical case for the fund is to invest in rounds with 4 participants. Despite the Cogepa, startups are often financed by Romulus Capital. The meaningful sponsors for the fund in investment in the same round are The Family, Romulus Capital, IDO Investments.

Read more

Funds with similar focus

Funds from France
Funds with similar focus located in France:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Alticor Corporate Enterprises Ada, Michigan, United States
AP Ventures England, London, United Kingdom
Atlanticus Atlanta, Georgia, United States
Besunyen (Beijing Outsell Health) China, Guangdong, Wanchai
Capital Today China, Shanghai
Castrol innoVentures Pangbourne, United Kingdom, West Berkshire
ComplySci New York, New York, United States
Dai-Dan Japan, Osaka, Osaka Prefecture
Dayli Partners Seoul, Seoul-t'ukpyolsi, South Korea
Grassy Creek Ventures California, Mill Valley, United States
INSA Angels France, Rhone-Alpes, Villeurbanne
LAB Miami Ventures Florida, Miami, United States
MedCity News Cleveland, Ohio, United States
PJ Tech Catalyst Athens, Attiki, Greece
Rage Capital -
Serica Partners -
Shunying Capital China, Guangdong, Zhuhai
Susquehanna International Group (SIG) Bala Cynwyd, Pennsylvania, United States
Zhong Ri Qing Nian Exchange Center Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Allurion Technologies

Health Care
Medical Device
$27M11 Jul 2017 United States, Wellesley


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cogepa?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: